APA ציטוט

Tano, K., Suematsu, Y., Tashiro, K., Kumagai-Koyanagi, N., Matsuo, Y., Kuwano, T., & Miura, S. (2019). Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia. J Clin Med Res.

Citação norma Chicago

Tano, Kanako, Yasunori Suematsu, Kohei Tashiro, Naoko Kumagai-Koyanagi, Yoshino Matsuo, Takashi Kuwano, and Shin-ichiro Miura. "Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia." J Clin Med Res 2019.

ציטוט MLA

Tano, Kanako, et al. "Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia." J Clin Med Res 2019.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.